Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ACI FormulationsDHA:ACIFORMULA +3.11%91 Return-on-Tangible-Equity is 8.78% as of Mar. 2026, which is 11% above its 10-year median of 7.93. GuruFocus rates DHA:ACIFORMULA with a GF Score™ of 91/100 and a GF Value™ of BDT150.73 (Fairly Valued). The stock has 4 warning signs investors should review. Among 251 Agriculture companies, ACI Formulations ranks better than 54.98% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. ACI Formulations's annualized net income for the quarter that ended in Mar. 2026 was BDT333 Mil. ACI Formulations's average shareholder tangible equity for the quarter that ended in Mar. 2026 was BDT3,793 Mil. Therefore, ACI Formulations's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2026 was 8.78%.
The historical rank and industry rank for ACI Formulations's Return-on-Tangible-Equity or its related term are showing as below:
DHA:ACIFORMULA'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 3.82 Med: 7.93 Max: 11.05
Current: 9.6
During the past 13 years, ACI Formulations's highest Return-on-Tangible-Equity was 11.05%. The lowest was 3.82%. And the median was 7.93%.
DHA:ACIFORMULA's Return-on-Tangible-Equity is ranked better than 54.98% of 251
companies
in the Agriculture industry
Industry Median: 6.96
vs DHA:ACIFORMULA: 9.60
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
ACI Formulations Return-on-Tangible-Equity Related Terms
ACI Formulations Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for ACI Formulations's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DHA:ACIFORMULA vs CTVA, CF, MOS: Return-on-Tangible-Equity Comparison
For the Agricultural Inputs subindustry, ACI Formulations's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ACI Formulations Return-on-Tangible-Equity vs Agriculture Industry
For the Agriculture industry and Basic Materials sector, ACI Formulations's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where ACI Formulations's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 8.78% mean?
ACI Formulations (DHA:ACIFORMULA) has a Return-on-Tangible-Equity of 8.78% as of Mar. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on ACI Formulations and its competitors. This is 11% above median its historical median of 7.93. Over the past decade, ACI Formulations' Return-on-Tangible-Equity has ranged from 3.82 to 11.05. According to the industry distribution chart, ACI Formulations ranks #113 out of 251 companies in the Agriculture industry, placing it in the top 45%.
Is ACI Formulations' Return-on-Tangible-Equity too high?
ACI Formulations' current Return-on-Tangible-Equity of 8.78% is 11% above median its 10-year median of 7.93. Over the past 10 years, this metric has ranged from a low of 3.82 to a high of 11.05. The Agriculture industry median Return-on-Tangible-Equity is 6.96. ACI Formulations' value of 8.78% is 26.1% above this industry median. Based on the distribution chart, ACI Formulations ranks #113 out of 251 companies in the Agriculture industry, which is above the industry midpoint. Overall, ACI Formulations has a GF Score™ of 91/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does ACI Formulations' Return-on-Tangible-Equity compare to CTVA and CF?
According to the Agriculture industry distribution chart, ACI Formulations ranks #113 out of 251 companies for Return-on-Tangible-Equity. This puts ACI Formulations in the upper half of its industry. The industry median Return-on-Tangible-Equity is 6.96. ACI Formulations' value of 8.78% is 26.1% above this benchmark. Historically, ACI Formulations' own Return-on-Tangible-Equity has ranged from 3.82 to 11.05 over the past decade. While the company's 10-year median is 7.93 vs. the industry median of 6.96, ACI Formulations has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for an Agriculture company?
The median Return-on-Tangible-Equity among Agriculture companies is 6.96, based on 251 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. ACI Formulations's current Return-on-Tangible-Equity of 8.78% is 26.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on ACI Formulations and its competitors. For the Agriculture industry, the median Return-on-Tangible-Equity is 6.96 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ACI Formulations's current Return-on-Tangible-Equity is 8.78%, which is 11% above median its own 10-year median of 7.93. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ACI Formulations stock overvalued right now?
Based on GuruFocus' analysis, ACI Formulations (DHA:ACIFORMULA) is currently considered Fairly Valued. The stock's GF Value™ is BDT150.73, compared to a current price of BDT152.70 — trading 1.3% above its estimated fair value. The current Return-on-Tangible-Equity is 8.78%, which is 11% above median its 10-year median of 7.93 and 26.1% above the Agriculture industry median of 6.96. ACI Formulations' overall GF Score™ is 91/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For ACI Formulations (DHA:ACIFORMULA), the current Return-on-Tangible-Equity is 8.78% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is ACI Formulations (DHA:ACIFORMULA) Overvalued in 2026?
Based on GuruFocus' analysis, ACI Formulations stock appears to be overvalued.
The current stock price of BDT152.70 is trading 1.3% above its estimated GF Value™ of BDT150.73.
GuruFocus considers ACI Formulations to be Fairly Valued.
Key valuation signals for DHA:ACIFORMULA:
Return-on-Tangible-Equity: 8.78% (11% above median its 10-year median of 7.93)
GF Value™: BDT150.73 vs. price of BDT152.70 (1.3% above fair value)
Industry Position: 26.1% above the Agriculture median (#113 of 251)
No single metric tells the full story. See the DHA:ACIFORMULA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
ACI Formulations PLC is engaged in the manufacturing and marketing of several agrochemical and consumer products. The company offers a complete range of cost-effective solutions for farmers through formulating and marketing insecticides, herbicides, fungicides, miticides, etc. Its businesses are Pharmaceuticals, Salt, Skincare & Antiseptics, Kitchen Care, Fabric Care, Surface Care, Herbal Care, Lavatory Care, and Others. The group's reportable segments are Crop Care and Public Health (CC & PH), which include manufacturing and selling crop care and public health products; Mosquito coil (M. Coil) includes manufacturing and selling mosquito coil products; Aerosol provides manufacturing and selling aerosol and air freshener products; and Paint covers manufacture and sell paint products.
91GF Score
Get the complete analysis for DHA:ACIFORMULA
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DHA:ACIFORMULA has been successfully added to your 
